Table 1.
Roles of Rap1 in tumor progression.
Roles of Rap1 | Tumor Types | Signaling Molecules | Results | Reference |
---|---|---|---|---|
Tumor promoter | Glioblastoma | Rap1A, thrombin, β1-integrin | Knockdown of Rap1A reduced more than 70% of tumor growth compared to control | [48] |
NSCLC | Rap1-GTP | Rap1-GTP depletion reduced growth of NSCLC cells and increased cisplatin sensitivity | [49] | |
Melanoma | Rap1-GTP, p38 | Rap1-GTP expression promoted melanoma migration and invasion | [50] | |
Breast cancer | Rap1-GTP, β1-integrin | Pharmacological inhibition of Rap1-GTP and β1-integrin reduced cell migration in breast cancer | [51] | |
Rap1 | Expression of dominant-active Rap1 in breast epithelial cells increased invasiveness and tumorigenicity | [43] | ||
Prostate cancer | Rap1A, α4, β3 -integrins | Rap1A activation increased expression of α4- and β3-integrins, leading to increased tumor cell invasion | [26] | |
Pancreatic cancer | Rap1-GTP, EGFR | Rap1-GTP activation promoted migration and EGFR-mediated metastasis of pancreatic cancer cells | [52] | |
Tumor suppressor | Bladder cancer | Rap1-GTP | Rap1-GTP activation suppressed migration of NBT-II bladder carcinoma cells | [53] |
NSCLC, non-small-cell lung carcinoma; EGFR, epidermal growth factor receptor.